For instance, extracellular α-synuclein breakdown using in vitro and in vivo model tests demonstrated that matrix metalloproteinase 2 (MMP-2) in the MSC-secretome decreased insoluble-synuclein oligomers and resulted in an improvement in neuronal survival in PD diseases [96]. Here, MMP2 is linked to Parkinson disease.